Study guide
15.2 Action Potentials, Synaptic Transmission & Muscle Contraction
APMLE Part I Basic Sciences Podiatry
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Lower Extremity Osteology
1.1 APMLE Part I Exam Structure, Policies & Scoring 1.2 Foot Osteology: Tarsals, Metatarsals, Phalanges & Sesamoids 1.3 Leg & Ankle Osteology: Tibia, Fibula & The Ankle Mortise 1.4 Pelvis, Femur & Patella Osteology: Landmarks & Biomechanics
2 Chapter 2: Lower Extremity Arthrology & Ligaments
2.1 Foot Articulations: Subtalar, Midtarsal, Lisfranc & Digital Joints 2.2 Talocrural (Ankle) & Knee Joints: Ligaments & Kinematics 2.3 Hip Joint & Pelvic Articulations: Capsular Structures & Dynamics
3 Chapter 3: Lower Extremity Myology & Compartments
3.1 Anterior & Lateral Compartments of the Leg 3.2 Superficial & Deep Posterior Compartments of the Leg 3.3 Plantar Layers & Intrinsic Musculature of the Foot 3.4 Thigh & Gluteal Musculature: Attachments & Innervations
4 Chapter 4: Lower Extremity Neurovascular & Topographical Anatomy
4.1 Lumbar & Sacral Plexuses, Peripheral Nerves & Dermatomes 4.2 Arterial Network, Venous Drainage & Lymphatics 4.3 Tarsal Tunnel, Femoral Triangle & Topographical Spaces
5 Chapter 5: Microbiology: Bacteriology, Zoonoses & Laboratory Methods
5.1 Gram-Positive Cocci & Bacilli in Podiatric Infections 5.2 Gram-Negative Bacilli & Opportunistic Pathogens 5.3 Anaerobic Pathogens & Diabetic Foot Infections 5.4 Bacterial Structure, Virulence Factors & Sterilization 5.5 Mycobacteria, Spirochetes, Mycoplasma & Zoonotic Infections 5.6 Antimicrobial Resistance, Susceptibility Testing, Specimen Handling & Vaccines
6 Chapter 6: Mycology, Virology, Parasitology & Clinical Immunology
6.1 Mycology: Dermatophytes, Onychomycosis & Systemic Mycoses 6.2 Clinically Relevant Viruses & Parasitic Infections 6.3 Innate & Adaptive Immunity Mechanisms 6.4 Hypersensitivity Reactions, Immunodeficiencies & Autoimmunity 6.5 Transplant & Tumor Immunology and Immunodiagnostic Methods
7 Chapter 7: General & Cellular Pathology
7.1 Cellular Injury, Adaptations & Cell Death Mechanisms 7.2 Acute vs Chronic Inflammation & Tissue Repair 7.3 Hemodynamic Disorders, Thrombosis, Embolism & Shock 7.4 Neoplasia, Oncogenes, Tumor Suppressors & Cutaneous Tumors
8 Chapter 8: Systemic & Podiatric Pathology
8.1 Atherosclerosis, Peripheral Artery Disease & Diabetic Microangiopathy 8.2 Osteoarthritis, Inflammatory Arthritides & Bone Infections 8.3 Neuropathic Disorders, Charcot Neuroarthropathy & Dermatopathology 8.4 Laboratory Diagnostics, Synovial Fluid & Biopsy Interpretation
9 Chapter 9: Organ-System Pathology
9.1 Anemias, Hemoglobinopathies, Leukemias & Immune Disorders 9.2 Cardiac & Pulmonary Pathology 9.3 Renal, Urogenital & Reproductive Pathology 9.4 Gastrointestinal, Hepatobiliary & Endocrine Pathology
10 Chapter 10: General Pharmacology, Autonomic Drugs & Toxicology
10.1 Pharmacokinetics, ADME & Receptor Dynamics 10.2 Cholinergic Agonists & Muscarinic/Nicotinic Antagonists 10.3 Adrenergic Agonists, Sympatholytics & Clinical Applications 10.4 Cardiovascular Pharmacology in Podiatric Patients 10.5 Drug Interactions, Adverse Effects, Pharmacogenomics & Toxicology
11 Chapter 11: Antimicrobial & Podiatric Therapeutics
11.1 Antibacterial Classes, Mechanisms & Resistances 11.2 Antifungal, Antiviral & Antiparasitic Therapeutics 11.3 NSAIDs, Opioids, Corticosteroids & Anti-Gout Agents 11.4 Local & General Anesthetic Pharmacology
12 Chapter 12: Systemic Pharmacology
12.1 Anticonvulsants, Antidepressants, Psychotropics & Skeletal Muscle Relaxants 12.2 Insulin & Noninsulin Glycemic Agents 12.3 Respiratory & Gastrointestinal Agents 12.4 DMARDs, Biologics, Antineoplastics & Immunosuppressants 12.5 Hormone Therapy, Bisphosphonates, Antihistamines, Growth Factors & Complementary Agents
13 Chapter 13: General Anatomy: Systemic Gross Anatomy & Neuroanatomy
13.1 Cranial Nerves, Head & Neck Anatomy 13.2 Thoracic Wall, Tracheobronchial Tree, Lungs & Mediastinum 13.3 Abdominal Wall, GI Viscera, Pelvis & Retroperitoneum 13.4 Vertebral Column, Spinal Cord & Upper Extremity Overview 13.5 Neuroanatomy: CNS Organization, Somatosensory & Motor Pathways
14 Chapter 14: Histology, Integument, Embryology & Genetics
14.1 Microscopic Anatomy: Epithelia, Connective Tissue, Muscle & Nerve 14.2 Integumentary System: Dermis, Appendages, Nail Unit & Cutaneous Receptors 14.3 Embryogenesis, Limb Morphogenesis & Postnatal Development 14.4 Medical Genetics & Structural Alterations in Aging
15 Chapter 15: Cellular, Neuromuscular & Cardiovascular Physiology
15.1 Membrane Potential, Ion Channels & Transport Mechanisms 15.2 Action Potentials, Synaptic Transmission & Muscle Contraction 15.3 Cardiac Electrophysiology, ECG & Hemodynamics 15.4 Blood Pressure Regulation, Poiseuille Law & Capillary Dynamics
16 Chapter 16: Organ-System Physiology: Respiratory, Renal, Endocrine, GI & Blood
16.1 Pulmonary Mechanics, Gas Exchange & Acid-Base Regulation 16.2 Renal Filtration, Tubular Transport & Fluid/Acid-Base Balance 16.3 Endocrine Regulation, Reproductive Hormones, Calcium & Bone 16.4 Gastrointestinal & Hepatobiliary Physiology 16.5 Hematology: Erythropoiesis, Leukocytes, Platelets & Coagulation 16.6 Exercise Physiology, Thermoregulation & Bone Mechanobiology
17 Chapter 17: Biochemistry: Proteins, Enzymes, Carbohydrates & Signaling
17.1 Amino Acid Chemistry, Protein Structure & Enzyme Kinetics 17.2 Glycolysis, Gluconeogenesis, Glycogen Metabolism & TCA Cycle 17.3 Electron Transport Chain, ATP Synthesis & Metabolic Inborn Errors 17.4 Hormones, Receptors, Second Messengers & Signal Transduction
18 Chapter 18: Biochemistry: Lipids, Molecular Genetics, Blood Chemistry & Nutrition
18.1 Fatty Acid Oxidation, Ketogenesis, Cholesterol & Lipoproteins 18.2 Nucleotide Metabolism, DNA Replication, Transcription, Translation & Repair 18.3 Vitamins, Micronutrients & Inborn Errors of Metabolism 18.4 Blood Chemistry: Heme Metabolism, Hemoglobin & Plasma Proteins 18.5 Nutrition: Energy Balance, Glycemic Index, Fed-Fast Cycle & Free Radicals
15.2 Action Potentials, Synaptic Transmission & Muscle Contraction
Key Takeaways Explain This Topic AI
The nerve action potential is initiated when membrane depolarization reaches threshold (-55 mV), triggering rapid opening of voltage-gated Na+ channels (NaV, m-gate opening; Hodgkin cycle), followed by time-dependent Na+ channel inactivation (h-gate closure) and delayed rectifier K+ channel (KV) opening; local anesthetics and tetrodotoxin block NaV channels, while refractory periods (absolute vs relative) enforce unidirectional propagation and maximum firing rates.
Axonal conduction velocity is directly determined by fiber diameter (reducing internal longitudinal axial resistance, ri) and myelination by Schwann cells (elevating transverse membrane resistance, rm, and decreasing membrane capacitance, Cm), enabling rapid saltatory conduction at Nodes of Ranvier (up to 120 m/s in A-alpha proprioceptive/motor fibers vs 0.5–2.0 m/s in unmyelinated C pain fibers).
Neuromuscular junction (NMJ) synaptic transmission begins when presynaptic terminal depolarization opens P/Q-type voltage-gated Ca2+ channels, driving synaptotagmin- and SNARE-mediated quantal exocytosis of acetylcholine (ACh) into the synaptic cleft; ACh binds postjunctional nicotinic Nm receptors to produce a depolarizing endplate potential (EPP), which is terminated rapidly by acetylcholinesterase (AChE).
Autoimmune NMJ disorders present distinct diagnostic profiles: Myasthenia Gravis features postjunctional IgG autoantibodies against nicotinic Nm ACh receptors, causing fatiguable weakness that worsens with repetitive exertion and exhibits a decremental compound muscle action potential (CMAP) response on low-frequency repetitive nerve stimulation; Lambert-Eaton Myasthenic Syndrome features paraneoplastic autoantibodies against prejunctional P/Q-type Ca2+ channels (linked to small cell lung cancer), presenting with proximal leg weakness and hyporeflexia that characteristically improves with exercise and displays an incremental CMAP response on high-frequency stimulation.
In skeletal muscle excitation-contraction coupling, T-tubule depolarization causes conformational activation of voltage-sensing dihydropyridine receptors (DHPR/CaV1.1), which mechanically open ryanodine receptors (RYR1) in sarcoplasmic reticulum terminal cisternae to release Ca2+; Ca2+ binds Troponin C, shifting tropomyosin off actin active sites; cross-bridge power strokes shorten sarcomeres (narrowing I-band and H-zone while A-band length remains constant); ATP binding detaches myosin (absence causes rigor mortis); relaxation requires SERCA Ca2+ reuptake; in contrast, smooth muscle lacks troponin, relying on Ca2+-Calmodulin activation of Myosin Light-Chain Kinase (MLCK) for contraction and MLCP for relaxation.
Last updated: October 2026
15.2 Action Potentials, Synaptic Transmission & Muscle Contraction
Independent Study Guide Notice: Independent study guide by ExamFinch. This educational resource is developed independently by ExamFinch and is not sponsored, endorsed, or affiliated with the National Board of Podiatric Medical Examiners (NBPME) or Meazure Learning.
Action Potential Electrophysiology: Phases, Gates & Refractory Periods
An action potential is a rapid, all-or-none, regenerative reversal of the membrane electrical potential that propagates along excitable membranes without decrement in signal amplitude. In human peripheral nerves and skeletal muscle fibers, the action potential represents the universal language for sensory transduction, motor command execution, and mechanical force generation.
The Biophysical Phases of the Action Potential Nerve Action Potential Electrophysiology
- Membrane
- Potential (mV)
- ▲
- +30 ┼ Peak / Overshoot (+30 to +40 mV)
- │ /\
- │ / \
- 0 ┼──────────────────/────\──────────────────────────────────
- │ / \ Phase 2: Repolarization
- │ Phase 1: / \ (NaV h-gates close;
- 55 ┼───Depolarization─────────\─ KV n-gates open)
- │ (Threshold) / \
- 70 ┼──────────────/ \ Phase 4: Baseline
- │ Resting Vm \ ┌────────────────────
- 90 ┼──────────────────────────────\_____/ Phase 3: After-Hyperpolarization
- │ (Delayed KV closure; Vm -> EK)
- └─────────────────────────────────────────────────────────►
- ◄──── ARP ──────►◄───── RRP ─────► Time (milliseconds)
- (Absolute (Relative
- Refractory) Refractory)
Resting State ( V m ≈ − 70 mV V_m \approx -70\text{ mV} V m ≈ − 70 mV in nerves; − 90 mV -90\text{ mV} − 90 mV in skeletal muscle):
High resting K + K^+ K + permeability through leak channels ( K i r , K 2 P K_{ir}, K_{2P} K i r , K 2 P ). Voltage-gated N a + Na^+ N a + channels ( N a V Na_V N a V ) and voltage-gated K + K^+ K + channels ( K V K_V K V ) are closed.
Threshold Depolarization ( − 55 mV -55\text{ mV} − 55 mV ):
A local graded depolarizing current (e.g., from an excitatory postsynaptic potential or mechanical deformation of a sensory receptor) shifts the membrane potential toward threshold.
Threshold is defined biophysically as the critical membrane voltage at which the inward sodium current ( I N a I_{Na} I N a ) exactly equals and begins to exceed the outward potassium current ( I K I_K I K ). Once threshold is reached, an action potential is irrevocably triggered ( All-or-None Phenomenon ).
Phase 1: Rapid Depolarization (Upstroke):
Depolarization above threshold triggers rapid conformational opening of the activation gates ( m m m -gates ) of voltage-gated sodium channels ( N a V 1.1 − 1.9 Na_V1.1-1.9 N a V 1.1 − 1.9 ).
Sodium ions rush into the axoplasm down their steep chemical and electrical gradients ( I N a I_{Na} I N a ). Inward sodium entry further depolarizes the membrane, opening additional N a V Na_V N a V channels in an explosive regenerative positive feedback loop ( The Hodgkin Cycle ).
Membrane potential surges toward the sodium equilibrium potential ( E N a ≈ + 62 mV E_{Na} \approx +62\text{ mV} E N a ≈ + 62 mV ), peaking at approximately + 30 to + 40 mV +30\text{ to } +40\text{ mV} + 30 to + 40 mV (the overshoot ). The peak never quite reaches E N a E_{Na} E N a because N a + Na^+ N a + channel inactivation begins rapidly and outward K + K^+ K + currents activate.
Phase 2: Repolarization:
Two distinct molecular events arrest the upstroke and drive repolarization:
Sodium Channel Inactivation: The intracellular inactivation gate ( h h h -gate , an aliphatic ball-and-chain peptide loop) swings into the inner pore of the N a V Na_V N a V channel, plugging it and halting inward N a + Na^+ N a + flux. This inactivation is time-dependent and voltage-sensitive.
Delayed Rectifier Potassium Channel Opening: Voltage-gated potassium channels ( K V K_V K V , four identical α \alpha α -subunits with n n n -gates) open with a deliberate temporal delay. Potassium rushes out of the axoplasm down its electrochemical gradient ( I K I_K I K ), rapidly restoring intracellular negativity.
Phase 3: After-Hyperpolarization (Undershoot):
Because voltage-gated K V K_V K V channels close sluggishly, potassium permeability ( P K P_K P K ) remains elevated above resting baseline for several milliseconds after repolarization.
The membrane potential transiently "undershoots" the resting baseline, dipping toward the potassium equilibrium potential ( E K ≈ − 95 mV E_K \approx -95\text{ mV} E K ≈ − 95 mV ).
Phase 4: Return to Resting Membrane Potential:
Voltage-gated K V K_V K V channels complete their closure. Baseline resting potential is re-established by non-gated K + K^+ K + leak channels and sustained by the electrogenic N a + / K + Na^+/K^+ N a + / K + ATPase.
Dual-Gate Structure of the Voltage-Gated N a + Na^+ N a + Channel ( N a V Na_V N a V )
The mammalian N a V Na_V N a V channel consists of a pore-forming α \alpha α -subunit with four homologous domains (I–IV), each containing six transmembrane α \alpha α -helices (S1–S6). Helix S4 contains positively charged arginine and lysine residues that act as the primary voltage sensor . Gating operates via two functional barriers:
Activation Gate ( m m m -gate): Located near the extracellular end of the pore. Closed at resting potential ( − 70 mV -70\text{ mV} − 70 mV ); opens rapidly upon depolarization above threshold ( − 55 mV -55\text{ mV} − 55 mV ).
Inactivation Gate ( h h h -gate): Formed by the intracellular loop linking domains III and IV (featuring a hydrophobic IFM motif: isoleucine-phenylalanine-methionine). Open at rest; swings closed slowly following depolarization, inactivating the channel.
Functional State Membrane Potential m m m -Gate (Activation) h h h -Gate (Inactivation) Channel Conductance Pharmacological Binding
Resting (Closed) − 70 mV -70\text{ mV} − 70 mV Closed Open Zero ( I N a = 0 I_{Na} = 0 I N a = 0 ) Low affinity for local anesthetics
Activated (Open) Depolarized ( − 55 to + 30 mV -55\text{ to } +30\text{ mV} − 55 to + 30 mV ) Open Open Maximal ( I N a I_{Na} I N a influx) High affinity for local anesthetics
Inactivated Late upstroke / Repolarization Open Closed (Plugged) Zero ( I N a = 0 I_{Na} = 0 I N a = 0 ) Highest affinity for local anesthetics
Refractory Periods: Absolute vs. Relative Absolute vs. Relative Refractory Period
- ┌────────────────────────────────────────────────────────┐
- │ ABSOLUTE REFRACTORY PERIOD (ARP) │
- │ - Extends from threshold upstroke to early Phase 2 │
- │ - NaV channels are either conducting or INACTIVATED │
- │ (h-gate closed/plugged) │
- │ - NO STIMULUS, regardless of magnitude, can elicit │
- │ a second action potential │
- │ - Enforces unidirectional anterograde propagation │
- │ - Sets absolute ceiling on action potential frequency │
- └───────────────────────────┬────────────────────────────┘
- │ Repolarization resets h-gates
- ▼
- ┌────────────────────────────────────────────────────────┐
- │ RELATIVE REFRACTORY PERIOD (RRP) │
- │ - Extends through late repolarization & undershoot │
- │ - Sufficient NaV channels have reset to resting state │
- │ (m closed, h open) │
- │ - KV conductance (P_K) remains elevated (undershoot) │
- │ - A SUPRATHRESHOLD STIMULUS (stronger than normal) │
- │ can trigger a second action potential │
- │ - Resulting action potential has lower peak amplitude │
- │ and slower upstroke velocity (dV/dt) │
- └────────────────────────────────────────────────────────┘
- Neurotoxins & Local Anesthetic Pharmacology
Tetrodotoxin (TTX) & Saxitoxin (STX):
TTX (derived from pufferfish liver and ovaries) and STX (dinoflagellate bloom / "red tide" paralytic shellfish poisoning) bind with nanomolar affinity to Site 1 on the outer extracellular pore vestibule of voltage-gated N a V Na_V N a V channels.
Physically occludes the channel pore, completely abolishing I N a I_{Na} I N a without affecting resting membrane potential or resting K + K^+ K + conductance. Produces profound perioral paresthesias, generalized motor paralysis, and fatal respiratory failure.
Local Anesthetics (Lidocaine, Bupivacaine, Mepivacaine, Ropivacaine):
Structurally comprise a lipophilic aromatic ring connected by an intermediate amide or ester chain to a hydrophilic tertiary amine.
Mechanism of Action: In tissue ( p H ≈ 7.4 pH \approx 7.4 p H ≈ 7.4 ), local anesthetics exist in equilibrium between uncharged base ( B B B ) and protonated cation ( B H + BH^+ B H + ). The uncharged, lipophilic base penetrates the perineurium and axonal phospholipid bilayer. Once inside the axoplasm, the molecule becomes protonated. The charged cationic form ( B H + BH^+ B H + ) binds with high affinity to a specific receptor pocket on the inner cytoplasmic vestibule of the N a V Na_V N a V channel (involving S6 segments of domains I, III, and IV).
Use-Dependent (Frequency-Dependent) Blockade: Local anesthetics bind preferentially to the open and inactivated states of N a V Na_V N a V channels rather than the closed resting state. Therefore, nerve fibers firing at high frequencies (such as nociceptive pain fibers stimulated by surgical incision or tissue trauma) are blocked with far greater rapidity and potency than quiescent fibers.
Tissue Acidosis Effect: In infected, inflamed, or ischemic foot tissue (e.g., a diabetic foot abscess or septic tenosynovitis with tissue p H < 6.0 pH < 6.0 p H < 6.0 ), the local acidic environment shifts the Henderson-Hasselbalch equilibrium heavily toward the charged cationic form ( B H + BH^+ B H + ). Because charged cations cannot cross the lipid bilayer, local anesthetic penetration into the axon is severely thwarted, explaining the notorious clinical failure of local field blocks in infected surgical fields.
- Axonal Conduction Velocity & Saltatory Conduction
- Cable Properties: Length and Time Constants
Passive electrical spread along an unmyelinated axon is governed by core cable equations:
Length (Space) Constant ( λ = r m / r i \lambda = \sqrt{r_m / r_i} λ = r m / r i ): The distance along the axon where a subthreshold potential decays to 37 % 37\% 37% ( 1 / e 1/e 1/ e ) of its initial voltage. To maximize λ \lambda λ (allowing passive current to travel farther before dying out), the membrane must possess high membrane resistance ( r m r_m r m ) and low internal axial axoplasmic resistance ( r i r_i r i ) .
Time Constant ( τ = r m ⋅ C m \tau = r_m \cdot C_m τ = r m ⋅ C m ): The time required for membrane potential to charge to 63 % 63\% 63% of its final value. A smaller τ \tau τ permits faster membrane depolarization and higher conduction velocity.
Biological Determinants of Conduction Velocity
Axon Diameter:
Internal longitudinal resistance is inversely proportional to cross-sectional area: r i ∝ 1 / ( π ⋅ r 2 ) r_i \propto 1 / (\pi \cdot r^2) r i ∝ 1/ ( π ⋅ r 2 ) .
Doubling axonal diameter quadruples cross-sectional area, drastically reducing internal resistance ( r i r_i r i ) and dramatically increasing the length constant ( λ \lambda λ ). Consequently, large-diameter axons conduct significantly faster than small-diameter axons.
Myelination:
In the peripheral nervous system, Schwann cells wrap concentrically around axons, laying down up to 100 layers of compacted, lipid-rich plasma membrane (myelin sheath). In the central nervous system, this role is performed by oligodendrocytes .
Myelin acts as a high-grade electrical insulator. It increases the physical separation between extracellular and intracellular charges, decreasing membrane capacitance ( C m ∝ 1 / thickness C_m \propto 1 / \text{thickness} C m ∝ 1/ thickness ). Furthermore, myelin seals the axonal membrane, preventing passive ion leakage and increasing transverse membrane resistance ( r m r_m r m ).
Lower C m C_m C m and higher r m r_m r m allow local electrotonic currents to spread passively over vast distances with lightning speed and negligible voltage loss.
Saltatory Conduction:
The myelin sheath is interrupted at regular intervals ( 1 − 2 mm 1-2\text{ mm} 1 − 2 mm ) by unmyelinated gaps ( 1 − 2 μ m 1-2\text{ }\mu\text{m} 1 − 2 μ m wide) termed the Nodes of Ranvier .
Voltage-gated N a V Na_V N a V channels are clustered at extraordinary density within the nodal axolemma ( ≈ 10 , 000 channels / μ m 2 \approx 10,000\text{ channels}/\mu\text{m}^2 ≈ 10 , 000 channels / μ m 2 ), anchored by the scaffolding cytoskeletal protein ankyrin-G .
In contrast, the internodal axolemma beneath the myelin sheath contains virtually zero N a V Na_V N a V channels. An action potential generated at one Node of Ranvier spreads electrotonically down the internode and depolarizes the subsequent node above threshold, causing the impulse to "jump" from node to node (saltatory conduction) . Conduction velocity reaches up to 120 m/s 120\text{ m/s} 120 m/s , compared to only 0.5 − 2.0 m/s 0.5-2.0\text{ m/s} 0.5 − 2.0 m/s in unmyelinated fibers.
Erlanger-Gasser Nerve Fiber Classification
Fiber Class Subtype Diameter ( μ m \mu\text{m} μ m ) Conduction Velocity ( m/s \text{m/s} m/s ) Myelination Primary Functional Distribution Local Anesthetic Block Sensitivity
Type A A- α \alpha α 12 − 20 12 - 20 12 − 20 70 − 120 70 - 120 70 − 120 Heavy Alpha motor neurons (skeletal muscle contraction); primary muscle spindle afferents (Ia) and Golgi tendon organs (Ib) Lowest sensitivity (blocked last)
A- β \beta β 5 − 12 5 - 12 5 − 12 30 − 70 30 - 70 30 − 70 Heavy Cutaneous touch, pressure, vibration mechanoreceptors (Meissner, Merkel, Pacinian); secondary spindle afferents (II) Intermediate-low sensitivity
A- γ \gamma γ 3 − 6 3 - 6 3 − 6 15 − 30 15 - 30 15 − 30 Medium Motor efferents to intrafusal muscle spindle fibers (regulates spindle sensitivity) Intermediate sensitivity
A- δ \delta δ 2 − 5 2 - 5 2 − 5 12 − 30 12 - 30 12 − 30 Thin Fast, sharp, localized, acute prickling pain ; cold temperature sensation; pinprick touch High sensitivity (blocked early)
Type B — 1 − 3 1 - 3 1 − 3 3 − 15 3 - 15 3 − 15 Light Preganglionic autonomic efferents Very high sensitivity
Type C Dorsal Root 0.4 − 1.2 0.4 - 1.2 0.4 − 1.2 0.5 − 2.0 0.5 - 2.0 0.5 − 2.0 Unmyelinated Slow, dull, burning, aching, chronic pain ; warm temperature sensation; itch; postganglionic sympathetic fibers Highest sensitivity (blocked first alongside A- δ \delta δ )
Note
Differential Susceptibility to Nerve Blockade: When performing an ankle block (blocking the tibial, deep fibular, superficial fibular, sural, and saphenous nerves) for podiatric surgery, the order of clinical loss is dictated by fiber diameter, myelination, and conduction frequency:
Pain (A- δ \delta δ and C fibers) and Temperature sensation are lost first.
Light touch and pressure sensation (A- β \beta β fibers) are lost next.
Proprioception and voluntary motor control (A- α \alpha α fibers) are lost last.
Conversely, nerve fibers exhibit differing vulnerabilities to other insults: pressure and mechanical compression (e.g., tarsal tunnel syndrome) selectively paralyze large, heavily myelinated fibers (A- α \alpha α , A- β \beta β ) first, whereas hypoxia and local ischemia selectively affect small unmyelinated fibers.
Neuromuscular Junction Synaptic Transmission
The neuromuscular junction (NMJ) is the specialized chemical synapse formed between the terminal bouton of an α \alpha α -motor neuron and the motor endplate of a skeletal muscle fiber. Transmission across this synapse converts an electrical nerve action potential into a muscular action potential with exceptional speed and reliability.
Presynaptic & Postsynaptic Cascade of the NMJ Neuromuscular Junction (NMJ) Synapse
- PRESYNAPTIC MOTOR TERMINAL
- ─────────────────────────────────────────────────────────────
- Action Potential Arrives ──► Depolarization opens P/Q-type Ca2+ Channels
- │
- ▼ Ca2+ Influx
- Binds Synaptotagmin
- │
- ▼ Assembles SNARE Pin
- (Synaptobrevin + Syntaxin + SNAP-25)
- │
- ▼
- QUANTAL EXOCYTOSIS OF ACh
- (~10,000 molecules per vesicle)
- ─────────────────────────────────────────────────────────────
- SYNAPTIC CLEFT (20-50 nm) │ ACh Diffuses Across Cleft
- │
- ├──────► Acetylcholinesterase (AChE)
- │ (Rapidly cleaves ACh to
- │ Choline + Acetate)
- ▼
- ─────────────────────────────────────────────────────────────
- POSTSYNAPTIC MOTOR ENDPLATE (Sarcolemmal Junctional Folds)
- Nicotinic Nm ACh Receptors (Pentameric: 2 alpha, 1 beta, 1 delta, 1 epsilon)
- │
- ▼ 2 ACh Molecules Bind
- Pore Opens: Massive Na+ Influx (Minor K+ Efflux)
- │
- ▼
- ENDPLATE POTENTIAL (EPP: Graded Depolarization)
- │
- ▼ Safety Factor Exceeds Threshold
- Adjacent Sarcolemmal NaV Channels Open ──► PROPAGATED MUSCLE ACTION POTENTIAL
Presynaptic Action Potential & Calcium Influx:
An action potential depolarizes the presynaptic motor nerve terminal, opening voltage-gated P/Q-type calcium channels ( C a V 2.1 Ca_V2.1 C a V 2.1 ) .
C a 2 + Ca^{2+} C a 2 + enters the terminal microdomain, increasing localized cytosolic calcium from 0.1 μ M 0.1\,\mu\text{M} 0.1 μ M to > 10 μ M >10\,\mu\text{M} > 10 μ M .
SNARE-Mediated Vesicle Fusion:
Intracellular C a 2 + Ca^{2+} C a 2 + binds to the calcium-sensor protein synaptotagmin-1 on the synaptic vesicle membrane.
Synaptotagmin triggers conformational zippering of the SNARE complex (SNARE pin) :
v-SNARE (vesicular): Synaptobrevin (also called VAMP: vesicle-associated membrane protein).
t-SNAREs (target plasmalemma): Syntaxin-1 and SNAP-25 (synaptosomal-associated protein 25 kDa).
Zippering pulls the synaptic vesicle flush against the presynaptic membrane, driving lipid bilayer fusion and exocytosis of approximately 60 − 200 vesicles (quanta) 60 - 200\text{ vesicles (quanta)} 60 − 200 vesicles (quanta) of acetylcholine (ACh) into the synaptic cleft.
Postsynaptic Nicotinic Activation:
ACh diffuses across the 20 − 50 nm 20-50\text{ nm} 20 − 50 nm synaptic cleft and binds to postjunctional nicotinic muscle-type acetylcholine receptors ( N m N_m N m ) concentrated at the crests of sarcolemmal junctional folds.
The N m N_m N m receptor is a pentameric ligand-gated ion channel composed of five glycoprotein subunits: ( α 1 ) 2 β 1 δ ϵ (\alpha_1)_2\beta_1\delta\epsilon ( α 1 ) 2 β 1 δϵ in mature adult muscle (in embryonic and denervated muscle, the γ \gamma γ -subunit substitutes for the ϵ \epsilon ϵ -subunit).
Simultaneous binding of two molecules of ACh (one to each α 1 \alpha_1 α 1 -subunit) triggers an allosteric conformational shift, opening the central hydrophilic pore (~ 0.65 nm 0.65\text{ nm} 0.65 nm diameter).
The channel is non-selectively permeable to monovalent cations ( N a + Na^+ N a + and K + K^+ K + ). Because the electrical and chemical driving forces on N a + Na^+ N a + are both overwhelmingly inward ( V m − E N a ≈ − 90 − ( + 62 ) = − 152 mV V_m - E_{Na} \approx -90 - (+62) = -152\text{ mV} V m − E N a ≈ − 90 − ( + 62 ) = − 152 mV ), whereas the forces on K + K^+ K + are small and outward ( V m − E K ≈ − 90 − ( − 95 ) = + 5 mV V_m - E_K \approx -90 - (-95) = +5\text{ mV} V m − E K ≈ − 90 − ( − 95 ) = + 5 mV ), the resulting current is an immense inward sodium flux .
The Endplate Potential (EPP) & Safety Factor:
Inward sodium flux produces a localized, non-propagated, graded depolarizing post-junctional potential termed the Endplate Potential (EPP) .
Under healthy physiological conditions, the EPP amplitude ( ≈ 40 − 50 mV \,\approx 40 - 50\text{ mV} ≈ 40 − 50 mV ) vastly exceeds the threshold depolarization required to open adjacent sarcolemmal voltage-gated N a V 1.4 Na_V1.4 N a V 1.4 channels ( ≈ 15 mV \,\approx 15\text{ mV} ≈ 15 mV ). This difference is termed the Safety Factor of Neuromuscular Transmission , guaranteeing that every single motor nerve impulse triggers a muscle action potential (1:1 fidelity).
Enzymatic Termination:
Acetylcholinesterase (AChE) , tethered to the collagenous basal lamina within the synaptic cleft, hydrolyzes ACh into acetate and choline within less than 1 millisecond ( k c a t ≈ 25 , 000 molecules/s k_{cat} \approx 25,000\text{ molecules/s} k c a t ≈ 25 , 000 molecules/s ).
High-affinity N a + Na^+ N a + -dependent choline transporters (ChT) pump choline back into the presynaptic terminal, where Choline Acetyltransferase (ChAT) resynthesizes acetylcholine from choline and acetyl-CoA.
Clinical NMJ Pathology: Myasthenia Gravis vs. Lambert-Eaton Syndrome
- Diagnostic / Clinical Feature Myasthenia Gravis (MG) Lambert-Eaton Myasthenic Syndrome (LEMS)
- Primary Anatomical Defect Postjunctional motor endplate Prejunctional motor nerve terminal
Autoantibody Target Anti-nicotinic ACh receptor (anti-AChR) (85%) or anti-MuSK (muscle-specific kinase) Anti-P/Q-type voltage-gated C a 2 + Ca^{2+} C a 2 + channels ( C a V 2.1 Ca_V2.1 C a V 2.1 )
Pathophysiology Autoantibody binding cross-links receptors, drives receptor endocytosis, and activates complement membrane attack complexes (MAC), flattening junctional folds and widening the synaptic cleft Blocks presynaptic C a 2 + Ca^{2+} C a 2 + influx, severely blunting C a 2 + Ca^{2+} C a 2 + -dependent quantal acetylcholine exocytosis
Clinical Distribution Extraocular muscles ( ptosis, diplopia ) in >50%; bulbar (dysarthria, dysphagia); proximal limb weakness Proximal lower extremities (difficulty rising from chair, climbing stairs); cranial nerves rarely affected
Response to Repetitive Use Fatiguable weakness : Symptoms worsen progressively with sustained or repetitive exertion and toward evening Facilitating weakness : Muscle strength and deep tendon reflexes IMPROVE transiently with sustained exercise
Deep Tendon Reflexes Normal (brisk) Markedly depressed or absent at baseline; return after brief isometric exercise
Autonomic Symptoms None Prominent autonomic dysfunction (xerostomia/dry mouth, erectile dysfunction, constipation, blurred vision)
Repetitive Nerve Stimulation (RNS) Decremental response (>10% drop in CMAP amplitude at 2–3 Hz stimulation) Incremental response (>100% surge in CMAP amplitude at high-frequency 20–50 Hz stimulation or post-exercise)
Associated Malignancy / Pathology Thymoma (15%) or thymic follicular hyperplasia (65%) Small Cell Lung Carcinoma (SCLC, 50–60%) ; classic neuroendocrine paraneoplastic syndrome
Pharmacotherapy Pyridostigmine (oral AChE inhibitor); corticosteroids; thymectomy Amifampridine (3,4-diaminopyridine) (blocks presynaptic K + K^+ K + channels, prolonging action potential and C a 2 + Ca^{2+} C a 2 + influx)
Microbial Neurotoxins Targeting the NMJ
Botulinum Neurotoxin ( Clostridium botulinum ): Light-chain zinc-dependent endopeptidase cleaves SNARE proteins (SNAP-25 by serotypes A and E; synaptobrevin by serotypes B, D, F, G). Completely halts vesicular exocytosis of acetylcholine, producing descending flaccid paralysis , mydriasis, and autonomic arrest.
Tetanus Toxin ( Clostridium tetani , Tetanospasmin): Retrograde axonal transport via motor nerves to the spinal cord anterior horn, crossing synapses to enter inhibitory Renshaw interneurons . Cleaves synaptobrevin, preventing exocytosis of inhibitory neurotransmitters GABA and glycine . Loss of spinal motor inhibition produces violent, uninhibited alpha-motor neuron discharge: spastic paralysis , lockjaw (trismus), risus sardonicus, and opisthotonos.
Excitation-Contraction Coupling in Skeletal Muscle
Excitation-Contraction (E-C) coupling is the physiological cascade that transforms an electrical sarcolemmal action potential into mechanical sarcomere shortening and tension generation.
Sarcotubular Architecture: The Triad
Transverse Tubules (T-tubules): Deep, narrow, tubular invaginations of the sarcolemma that penetrate radially into the muscle interior, positioned specifically at the junction of the A-band and I-band (A-I junction) in mammalian skeletal muscle (two T-tubules per sarcomere). T-tubules conduct the action potential deep into the fiber core.
Terminal Cisternae: Dilated blind-ended sacs of the sarcoplasmic reticulum ( S R SR SR ) flanking the T-tubule on both sides, sequestering high concentrations of C a 2 + Ca^{2+} C a 2 + bound to the storage protein calsequestrin .
The Triad: Composed of one central T-tubule flanked by two terminal cisternae .
Molecular Coupling: DHPR to RYR1
Within the T-tubule membrane sits the Dihydropyridine Receptor (DHPR / C a V 1.1 Ca_V1.1 C a V 1.1 ) , an L-type voltage-gated calcium channel that functions in skeletal muscle as a voltage sensor .
Located in the adjacent terminal cisterna membrane is the Ryanodine Receptor Type 1 (RYR1) , a massive homotetrameric calcium-release channel.
Mechanical Gating Mechanism: Unlike cardiac muscle, skeletal muscle does NOT require extracellular calcium entry to trigger contraction . Instead, action potential depolarization down the T-tubule alters the conformation of DHPR, which physically "unplugs" and mechanically opens the RYR1 channel via direct peptide loop interaction. Calcium floods out of the SR into the myoplasm down a 10 , 000 10,000 10 , 000 -fold concentration gradient, increasing free cytosolic [ C a 2 + ] [Ca^{2+}] [ C a 2 + ] from 0.1 μ M 0.1\,\mu\text{M} 0.1 μ M to 10 − 20 μ M 10 - 20\,\mu\text{M} 10 − 20 μ M . Skeletal Muscle Cross-Bridge Cycle
- RESTING STATE (Blocked by Tropomyosin)
- Actin Binding Sites Covered; Myosin Cocked (ADP + Pi)
- │
- ▼ Cytosolic Ca2+ Rises
- Ca2+ Binds Troponin C (TnC)
- Conformational Shift Moves Tropomyosin Off Actin Sites
- │
- ▼
- CROSS-BRIDGE FORMATION
- Myosin Head Binds Exposed Active Site on F-Actin
- │
- ▼
- ┌────────────────────────────────────────────────────────┐
- │ POWER STROKE │
- │ 1. Inorganic Phosphate (Pi) is released │
- │ 2. Myosin head flexes 45°, pulling actin toward M-line │
- │ 3. ADP is released; Sarcomere Shortens: │
- │ - Z-lines approximate │
- │ - I-band narrows; H-zone narrows/disappears │
- │ - A-BAND REMAINS STRICTLY CONSTANT │
- └───────────────────────────┬────────────────────────────┘
- │
- ▼
- RIGOR STATE (Myosin locked to actin)
- │
- ▼ NEW ATP BINDS MYOSIN HEAD
- DETACHMENT OF CROSS-BRIDGE
- (ATP binding induces allosteric release)
- [ABSENCE OF ATP = RIGOR MORTIS]
- │
- ▼ Myosin ATPase Hydrolyzes ATP -> ADP + Pi
- RECOCKING OF MYOSIN HEAD
- Myosin resets to 90° high-energy configuration
- The Sarcomere & Banding Dynamics During Contraction
The sarcomere is the smallest functional contractile unit of striated muscle, bounded by two successive Z-lines (Z-discs) :
A-Band (Anisotropic): Encompasses the entire length of thick myosin filaments. The width of the A-band remains strictly CONSTANT during muscle contraction, stretching, and relaxation .
I-Band (Isotropic): Contains only thin actin filaments (bisected by the Z-line). Narrows during contraction .
H-Zone: Pale central zone within the A-band containing thick myosin filaments without actin overlap. Narrows and can disappear during maximal contraction .
Z-Lines: Anchor thin actin filaments via α \alpha α -actinin. Approximate (move closer together) during contraction .
The Cross-Bridge Cycle & Rigor Mortis
Resting State: Tropomyosin physically blocks the myosin-binding sites on the actin filament. Troponin consists of three subunits: TnT (binds tropomyosin), TnI (inhibits actomyosin ATPase), and TnC (possesses four C a 2 + Ca^{2+} C a 2 + -binding sites). The myosin head is detached from actin, carrying bound ADP and inorganic phosphate ( P i P_i P i ) in a "cocked" 90° high-energy conformation.
Calcium Activation: Depolarization releases SR calcium; C a 2 + Ca^{2+} C a 2 + binds Troponin C. This induces a conformational change that rolls tropomyosin deep into the actin groove, exposing the active myosin-binding sites on G-actin.
Cross-Bridge Binding: The energized myosin head binds to actin, forming a physical cross-bridge.
The Power Stroke: Release of inorganic phosphate ( P i P_i P i ) tightens actomyosin binding and triggers the mechanical power stroke: the myosin neck pivots from 90° to 45°, pulling the thin actin filament ≈ 10 nm \approx 10\text{ nm} ≈ 10 nm toward the center of the sarcomere (M-line). Following the stroke, ADP is released.
Detachment: A new molecule of ATP binds to the nucleotide pocket on the myosin head. ATP binding causes an immediate allosteric drop in myosin's affinity for actin, causing the myosin head to detach from actin .
Biochemical Cause of Rigor Mortis: Upon somatic death, cellular respiration halts, depleting intracellular ATP stores. Without ATP, the myosin head cannot detach from actin. Cross-bridges remain locked in the rigid 45° actomyosin configuration, producing post-mortem muscular stiffening ( rigor mortis ), which commences 2–4 hours post-mortem and resolves after 48–72 hours as endogenous lysosomal proteases degrade contractile proteins.
ATP Hydrolysis (Recocking): The intrinsic myosin ATPase activity hydrolyzes bound ATP into ADP and P i P_i P i . The released free energy recocks the myosin head back to the 90° high-energy state.
Relaxation: Cytosolic calcium is actively pumped back into the SR by the SERCA1a ATPase . Cytosolic [ C a 2 + ] [Ca^{2+}] [ C a 2 + ] drops below 0.1 μ M 0.1\,\mu\text{M} 0.1 μ M , C a 2 + Ca^{2+} C a 2 + dissociates from Troponin C, and tropomyosin re-covers the actin active sites.
Important
Malignant Hyperthermia (MH) Pathophysiology: Malignant hyperthermia is an autosomal dominant pharmacogenetic crisis caused by gain-of-function mutations in the RYR1 gene (chromosome 19q13.1) encoding the skeletal muscle ryanodine receptor. Exposure to volatile inhalational anesthetics ( halothane, isoflurane, sevoflurane ) or depolarizing neuromuscular blockers ( succinylcholine ) triggers uncontrolled, sustained, massive efflux of calcium from the SR into the myoplasm. Unchecked cross-bridge cycling and hyperactive SERCA pumping exhaust ATP stores, driving an explosive hypermetabolic state characterized by masseter muscle spasm/trismus, generalized muscle rigidity, hypercapnia, severe combined metabolic/respiratory acidosis, rhabdomyolysis, hyperkalemia, and lethal hyperthermia (>42°C) . The definitive antidote is intravenous Dantrolene , a hydantoin derivative that directly antagonizes RYR1 , shutting off pathological calcium release from the sarcoplasmic reticulum.
Smooth Muscle Physiology: Calmodulin & Phosphorylation Dynamics
Smooth muscle lines the walls of hollow visceral organs and blood vessels (including lower extremity digital arterioles, metatarsal arteries, and tibial arteries). It is non-striated, involuntary, and structurally distinct from skeletal and cardiac muscle.
Structural Features
Spindle-shaped (fusiform) mononucleated cells lacking sarcomeres and T-tubules (plasmalemmal invaginations termed caveolae substitute for T-tubules).
Actin thin filaments crisscross the sarcoplasm and anchor to electron-dense structures termed dense bodies (in cytoplasm) and dense plaques (along sarcolemma). Dense bodies contain α \alpha α -actinin and serve as functional analogues to Z-lines.
Smooth muscle completely lacks the troponin complex (no TnT, TnI, TnC) . Contractile regulation is myosin-linked rather than actin-linked.
The Calmodulin-MLCK Contractile Pathway Smooth Muscle Contraction & Relaxation
- Agonist (NE, Ang II, Endothelin) Endothelial Nitric Oxide (NO)
- via Gq / L-type Ca2+ Channels │
- │ ▼
- ▼ [Soluble Guanylyl Cyclase]
- Cytosolic [Ca2+] Rises │
- │ ▼
- ▼ [cyclic GMP (cGMP)]
- Binds CALMODULIN │
- (4 Ca2+ ions) ▼
- │ [Protein Kinase G (PKG)]
- ▼ │
- [Ca2+-Calmodulin Complex] ├────────┐
- │ │ │
- ▼ Activates ▼ ▼
- MYOSIN LIGHT-CHAIN KINASE (MLCK) Stimulates Blocks Ca2+
- │ MLCP Influx
- ▼ Phosphorylates │ │
- Myosin Regulatory Light Chain │ │
- │ ▼ ▼
- ▼ DEPHOSPHORYLATES
- Actin-Myosin Cross-Bridge MYOSIN LIGHT CHAIN
- Cycling & Contraction │
- │ ▼
- ▼ (Low ATP Latch State) RELAXATION & VASODILATION
- Tonic Vasomotor Tone (Digital Arterial Inflow)
Calcium Entry: Calcium enters the cytoplasm via voltage-gated L-type C a 2 + Ca^{2+} C a 2 + channels ( C a V 1.2 Ca_V1.2 C a V 1.2 ), receptor-operated calcium channels, or is released from the SR via inositol trisphosphate ( I P 3 IP_3 I P 3 )-gated channels (triggered by Gq-coupled vasoconstrictors: norepinephrine via α 1 \alpha_1 α 1 , angiotensin II via A T 1 AT_1 A T 1 , endothelin-1 via E T A ET_A E T A ).
Calmodulin Activation: Four C a 2 + Ca^{2+} C a 2 + ions bind to the ubiquitous calcium-sensor protein calmodulin .
MLCK Phosphorylation: The C a 2 + Ca^{2+} C a 2 + -calmodulin complex binds and activates Myosin Light-Chain Kinase (MLCK) .
Cross-Bridge Cycling: Activated MLCK phosphorylates the regulatory light chain (RLC, 20 kDa 20\text{ kDa} 20 kDa ) of the myosin head. Phosphorylation activates myosin ATPase, permitting cross-bridge interaction with actin and contraction.
The Latch State: In vascular smooth muscle, dephosphorylation of myosin by phosphatase while the cross-bridge is still bound to actin creates a long-lived "latch state." Latch-bridges cycle at an extraordinarily slow rate with minimal ATP consumption, sustaining tonic vascular resistance and blood pressure for hours without muscle fatigue.
Relaxation via MLCP & Nitric Oxide (NO):
Relaxation requires dephosphorylation of myosin light chains by Myosin Light-Chain Phosphatase (MLCP) .
Endothelial cells synthesize Nitric Oxide (NO) from L-arginine via endothelial nitric oxide synthase (eNOS). NO diffuses into vascular smooth muscle, activating soluble guanylyl cyclase (sGC) to generate cyclic GMP (cGMP) .
cGMP activates Protein Kinase G (PKG) . PKG: (1) phosphorylates and activates MLCP, (2) blocks L-type C a 2 + Ca^{2+} C a 2 + channels, and (3) stimulates SERCA and BK potassium channels. The resulting drop in sarcoplasmic calcium and accelerated myosin dephosphorylation drives profound arteriolar relaxation and vasodilation .